Coegin Pharma (FRA:7Z6) FFO


FRA:7Z6 Coegin Pharma FRA:7Z6
38 GF Score
Price €0.28
! 2 Warning Signs
View Full Analysis

What is Coegin Pharma FFO?

FFO (Funds from operations) only applies to REITs.

FRA:7Z6
38GF Score
Coegin Pharma FRA:7Z6
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Coegin Pharma Business Description

Other Exchanges COEGIN:Sweden
Address c/o Medicon Village, Lund, SWE, 223 81
Coegin Pharma AB is a Swedish biotechnology company with projects in hair growth, skin pigmentation, heart attacks, and leukemia. Its project portfolio builds on three distinct, patented technology platforms: the FOL peptide technology, the pigmentation peptide technology, and the cPLA2 alpha technology. The company's project portfolio consists of both cosmetic dermatology and drug development projects. Currently, it is focused on the cosmetic dermatology projects, which include the NPP-4 project for skin pigmentation and the Follicopeptide project for hair growth. In addition, the company's project portfolio also includes three drug development projects: FOL026, for the treatment of myocardial infarction (heart attack); AVX420 for the treatment of leukemia; and AVX001.
38GF Score

Get the complete analysis for FRA:7Z6

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.28
Price